Surmodics Inc logo

Surmodics Inc

NAS:SRDX (USA)  
$ 27.47 -0.7 (-2.48%) 11:09 PM EST
72.29
P/B:
3.20
Market Cap:
$ 391.06M
Enterprise V:
$ 398.59M
Volume:
35.10K
Avg Vol (2M):
42.38K
Also Trade In:
Volume:
35.10K
Avg Vol (2M):
42.38K

Business Description

Surmodics Inc logo
Surmodics Inc
NAICS : 325413 SIC : 3845
ISIN : US8688731004
Description
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Name Current Vs Industry Vs History
Cash-To-Debt 1.04
Equity-to-Asset 0.68
Debt-to-Equity 0.28
Debt-to-EBITDA 1.54
Interest Coverage 3.51
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.23
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 11.76
9-Day RSI 21.56
14-Day RSI 28.41
6-1 Month Momentum % -7.37
12-1 Month Momentum % 81.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.84
Quick Ratio 3.97
Cash Ratio 2.13
Days Inventory 72.34
Days Sales Outstanding 30.48
Days Payable 14.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.2
Shareholder Yield % -3.7

Financials (Next Earnings Date:2024-04-26 Est.)

SRDX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SRDX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Surmodics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 138.203
EPS (TTM) ($) 0.38
Beta 1.27
Volatility % 80.48
14-Day RSI 28.41
14-Day ATR ($) 1.201976
20-Day SMA ($) 30.737
12-1 Month Momentum % 81.08
52-Week Range ($) 16 - 39.41
Shares Outstanding (Mil) 14.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Surmodics Inc Filings

Filing Date Document Date Form
No Filing Data

Surmodics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Surmodics Inc Frequently Asked Questions

What is Surmodics Inc(SRDX)'s stock price today?
The current price of SRDX is $27.47. The 52 week high of SRDX is $39.41 and 52 week low is $16.00.
When is next earnings date of Surmodics Inc(SRDX)?
The next earnings date of Surmodics Inc(SRDX) is 2024-04-26 Est..
Does Surmodics Inc(SRDX) pay dividends? If so, how much?
Surmodics Inc(SRDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1